Sectors & IndustriesHealthcareHealth Information Services
Best Health Information Service Stocks to Buy Now (2026)
Top health information service stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best health information service stocks to buy now. Learn More.

Industry: Health Information Servic...
B
Health Information Services is Zen Rated B and is the 34th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
TBRG
TRUBRIDGE INC
$331.10M$22.06$23.004.26%Hold14.80%479.03%20.40%9.21%
NUTX
NUTEX HEALTH INC
$884.70M$125.10$205.0063.87%Strong Buy15.89%1.04%59.00%19.40%
OPRX
OPTIMIZERX CORP
$205.42M$11.02$19.6778.47%Buy312.18%N/A16.33%11.72%
DH
DEFINITIVE HEALTHCARE CORP
$290.39M$2.05$4.25107.32%Hold3-0.46%N/A14.71%5.55%
BTSG
BRIGHTSPRING HEALTH SERVICES INC
$6.72B$37.28$42.6714.45%Strong Buy916.40%52.74%33.13%9.96%
PHR
PHREESIA INC
$773.48M$12.83$30.75139.67%Strong Buy1610.82%N/AN/AN/A
CCLD
CARECLOUD INC
$103.45M$2.44N/AN/AN/AN/A17.97%180.50%14.21%9.07%
OMCL
OMNICELL INC
$2.10B$46.69$54.6016.94%Strong Buy53.84%77.91%N/AN/A
WAY
WAYSTAR HOLDING CORP
$4.59B$23.99$45.3689.10%Strong Buy1114.90%48.75%15.47%10.50%
TALK
TALKSPACE INC
$644.40M$3.89$4.8825.32%Strong Buy426.51%159.17%N/AN/A
PGNY
PROGYNY INC
$1.96B$22.77$28.0022.97%Buy710.76%46.32%36.43%25.65%
HQY
HEALTHEQUITY INC
$6.95B$81.34$117.4044.33%Buy105.46%44.88%21.34%13.40%
CERT
CERTARA INC
$1.21B$7.61$12.7567.54%Strong Buy88.57%119.65%16.17%11.21%
SOLV
SOLVENTUM CORP
$13.27B$76.49$92.6321.09%Buy81.37%-3.61%N/AN/A
DOCS
DOXIMITY INC
$6.64B$35.25$66.1487.64%Buy149.27%13.21%37.69%32.84%
WGS
GENEDX HOLDINGS CORP
$2.47B$85.35$167.0095.66%Strong Buy523.83%182.03%42.15%24.94%
TXG
10X GENOMICS INC
$2.41B$19.06$18.44-3.23%Buy94.03%N/A4.07%3.11%
HNGE
HINGE HEALTH INC
$2.62B$33.25$63.3990.63%Strong Buy13N/AN/A112.34%30.35%
GDRX
GOODRX HOLDINGS INC
$750.15M$2.21$4.3295.52%Buy76.67%101.06%57.64%26.12%
OWLT
OWLET INC
$313.04M$11.35$20.0076.21%Buy128.06%N/A-56.64%40.96%
HSTM
HEALTHSTREAM INC
$605.23M$20.40$28.0037.25%Hold15.25%18.10%N/AN/A
GEHC
GE HEALTHCARE TECHNOLOGIES INC
$37.66B$82.63$89.738.59%Buy114.73%10.50%28.35%7.97%
WEAV
WEAVE COMMUNICATIONS INC
$493.12M$6.32$10.3363.50%Strong Buy322.01%N/A18.89%7.19%
VEEV
VEEVA SYSTEMS INC
$31.35B$190.69$314.4064.87%Buy209.76%23.18%26.87%23.36%
SLP
SIMULATIONS PLUS INC
$298.57M$14.82$19.0028.21%Hold16.95%N/A20.49%18.90%
NRC
NATIONAL RESEARCH CORP
$345.98M$15.27N/AN/AN/AN/AN/AN/AN/AN/A
OMDA
OMADA HEALTH INC
$782.34M$13.51$24.8683.99%Buy7N/AN/A5.67%4.29%
PRVA
PRIVIA HEALTH GROUP INC
$2.71B$22.01$30.5038.57%Strong Buy1013.12%56.77%N/AN/A
TEM
TEMPUS AI INC
$9.53B$53.55$89.2566.67%Strong Buy843.77%N/A12.38%2.76%
SPOK
SPOK HOLDINGS INC
$278.08M$13.50N/AN/AN/AN/AN/AN/A11.73%8.32%
TDOC
TELADOC HEALTH INC
$871.39M$4.91$8.3069.04%Hold52.75%N/A-9.75%-4.72%
ONMD
ONEMEDNET CORP
$41.93M$0.82N/AN/AN/AN/AN/AN/AN/AN/A
HCAT
HEALTH CATALYST INC
$153.49M$2.17$3.9481.47%Buy80.17%N/A8.04%4.55%
SOPH
SOPHIA GENETICS SA
$339.24M$5.00$7.0040.00%Strong Buy220.88%N/AN/AN/A
SDGR
SCHRODINGER INC
$984.16M$13.36$21.7562.80%Buy818.28%N/A-5.61%-2.76%
HTFL
HEARTFLOW INC
$2.40B$28.14$39.2039.30%Strong Buy5N/AN/A-11.59%-8.10%
CTEV
CLARITEV CORP
$416.45M$25.20$60.67140.74%Strong Buy36.83%N/AN/A-4.25%
SY
SO-YOUNG INTERNATIONAL INC
$293.93M$2.95N/AN/AN/AN/A1,119.73%N/A82.80%52.31%
ACON
ACLARION INC
$1.81M$2.70$23.00751.85%Buy1N/AN/A-75.11%-71.12%
CARL
CARLSMED INC
$306.08M$11.51$20.2575.93%Strong Buy4N/AN/A-27.21%-21.52%
AMWL
AMERICAN WELL CORP
$72.03M$4.40$7.0059.09%Buy3-0.90%N/AN/AN/A
EVH
EVOLENT HEALTH INC
$341.50M$3.06$9.80220.26%Strong Buy1014.57%N/A12.85%4.41%
LFMD
LIFEMD INC
$147.78M$3.07$8.50176.87%Strong Buy6-0.77%N/A-74.71%-1.49%
BEAT
HEARTBEAM INC
$47.88M$1.39$6.75385.61%Strong Buy2N/AN/A-3,963.55%-559.53%
FORA
FORIAN INC
$65.25M$2.10N/AN/AN/AN/AN/AN/A9.18%6.91%
VSEE
VSEE HEALTH INC
$11.60M$0.37N/AN/AN/AN/AN/AN/AN/A-41.02%
EUDA
EUDA HEALTH HOLDINGS LTD
$44.96M$1.21N/AN/AN/AN/AN/AN/A-173.68%303.56%
ZCMD
ZHONGCHAO INC
$9.62M$0.38N/AN/AN/AN/AN/AN/AN/AN/A
BFRG
BULLFROG AI HOLDINGS INC
$6.33M$0.56N/AN/AN/AN/AN/AN/AN/AN/A
MGRX
MANGOCEUTICALS INC
$4.95M$0.36N/AN/AN/AN/AN/AN/AN/AN/A
HCTI
HEALTHCARE TRIANGLE INC
$1.69M$0.23N/AN/AN/AN/A52.83%N/A16.94%10.70%
MNDR
MOBILE-HEALTH NETWORK SOLUTIONS
$1.13M$0.96N/AN/AN/AN/AN/AN/A0.92%0.54%
ALPS
ALPS GROUP INC
$152.76M$0.92N/AN/AN/AN/AN/AN/AN/AN/A
WORX
SCWORX CORP
$2.74M$0.17N/AN/AN/AN/AN/AN/AN/AN/A

Health Information Service Stocks FAQ

What are the best health information service stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:

1. Trubridge (NASDAQ:TBRG)


Trubridge (NASDAQ:TBRG) is the #1 top health information service stock out of 54 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Trubridge (NASDAQ:TBRG) is: Value: B, Growth: B, Momentum: C, Sentiment: C, Safety: B, Financials: B, and AI: C.

Trubridge (NASDAQ:TBRG) has a Due Diligence Score of 29, which is equal to the health information service industry average of 29.

TBRG passed 11 out of 38 due diligence checks and has average fundamentals. Trubridge has seen its stock lose -15.19% over the past year, overperforming other health information service stocks by 16 percentage points.

Trubridge has an average 1 year price target of $23.00, an upside of 4.26% from Trubridge's current stock price of $22.06.

Trubridge stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Trubridge, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Nutex Health (NASDAQ:NUTX)


Nutex Health (NASDAQ:NUTX) is the #2 top health information service stock out of 54 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Nutex Health (NASDAQ:NUTX) is: Value: A, Growth: C, Momentum: C, Sentiment: C, Safety: F, Financials: B, and AI: C.

Nutex Health (NASDAQ:NUTX) has a Due Diligence Score of 57, which is 28 points higher than the health information service industry average of 29.

NUTX passed 18 out of 33 due diligence checks and has strong fundamentals. Nutex Health has seen its stock return 156.93% over the past year, overperforming other health information service stocks by 188 percentage points.

Nutex Health has an average 1 year price target of $205.00, an upside of 63.87% from Nutex Health's current stock price of $125.10.

Nutex Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Nutex Health, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Optimizerx (NASDAQ:OPRX)


Optimizerx (NASDAQ:OPRX) is the #3 top health information service stock out of 54 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Optimizerx (NASDAQ:OPRX) is: Value: C, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Optimizerx (NASDAQ:OPRX) has a Due Diligence Score of 29, which is equal to the health information service industry average of 29.

OPRX passed 9 out of 33 due diligence checks and has average fundamentals. Optimizerx has seen its stock return 90.33% over the past year, overperforming other health information service stocks by 122 percentage points.

Optimizerx has an average 1 year price target of $19.67, an upside of 78.47% from Optimizerx's current stock price of $11.02.

Optimizerx stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Optimizerx, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the health information service stocks with highest dividends?

Out of 5 health information service stocks that have issued dividends in the past year, the 3 health information service stocks with the highest dividend yields are:

1. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.26%, which is 6 percentage points higher than the health information service industry average of 2.87%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. National Research (NASDAQ:NRC)


National Research (NASDAQ:NRC) has an annual dividend yield of 3.41%, which is 1 percentage points higher than the health information service industry average of 2.87%. National Research's dividend payout is not stable, having dropped more than 10% four times in the last 10 years. National Research's dividend has not shown consistent growth over the last 10 years.

National Research's dividend payout ratio of 67.6% indicates that its dividend yield is sustainable for the long-term.

3. So Young International (NASDAQ:SY)


So Young International (NASDAQ:SY) has an annual dividend yield of 0.9%, which is -2 percentage points lower than the health information service industry average of 2.87%.

So Young International's dividend payout ratio of -2.6% indicates that its dividend yield might not be sustainable for the long-term.

Why are health information service stocks down?

Health information service stocks were down -3.6% in the last day, and down -8.97% over the last week.

We couldn't find a catalyst for why health information service stocks are down.

What are the most undervalued health information service stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued health information service stocks right now are:

1. Nutex Health (NASDAQ:NUTX)


Nutex Health (NASDAQ:NUTX) is the most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 86, which is 64 points higher than the health information service industry average of 22. It passed 6 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 156.93% in the past year. It has overperformed other stocks in the health information service industry by 188 percentage points.

2. Goodrx Holdings (NASDAQ:GDRX)


Goodrx Holdings (NASDAQ:GDRX) is the second most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Goodrx Holdings has a valuation score of 86, which is 64 points higher than the health information service industry average of 22. It passed 6 out of 7 valuation due diligence checks.

Goodrx Holdings's stock has dropped -54.15% in the past year. It has underperformed other stocks in the health information service industry by -23 percentage points.

3. Solventum (NYSE:SOLV)


Solventum (NYSE:SOLV) is the third most undervalued health information service stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Solventum has a valuation score of 43, which is 21 points higher than the health information service industry average of 22. It passed 3 out of 7 valuation due diligence checks.

Solventum's stock has gained 2.52% in the past year. It has overperformed other stocks in the health information service industry by 34 percentage points.

Are health information service stocks a good buy now?

48.72% of health information service stocks rated by analysts are a strong buy right now. On average, analysts expect health information service stocks to rise by 57.69% over the next year.

6.82% of health information service stocks have a Zen Rating of A (Strong Buy), 27.27% of health information service stocks are rated B (Buy), 54.55% are rated C (Hold), 9.09% are rated D (Sell), and 2.27% are rated F (Strong Sell).

What is the average p/e ratio of the health information services industry?

The average P/E ratio of the health information services industry is 26.77x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.